CC
CNTB

Callan Capital’s Connect Biopharma Holdings CNTB Stock Holding History

Callan Capital’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$44K Hold
80,000
– – ﹤0.01% 361
2024
Q4 		$110K Buy
80,000
+38,177
+91% +$44K 0.01% 333
2024
Q3 		$60.2K Buy
+41,823
New +$51K ﹤0.01% 345

Other funds holding CNTB

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $9.11B AUM 26.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

Callan Capital's CNTB Position: Q1 2025 in Review

Callan Capital held its Connect Biopharma Holdings (CNTB) position steady in Q1 2025 at 80,000 shares worth $44K. The position accounts for ﹤0.01% of the portfolio, ranked #361.

Callan Capital first reported a position in CNTB in Q3 2024 and has held it in 3 quarters since. The position peaked at $110K in Q4 2024. 13 funds tracked by Wall St. Rank hold CNTB as of Q1 2025.

  • Callan Capital held 80,000 shares of Connect Biopharma Holdings worth $44K as of Q1 2025.
  • Callan Capital left its Connect Biopharma Holdings share count unchanged in Q1 2025.
  • Connect Biopharma Holdings made up ﹤0.01% of Callan Capital's portfolio in Q1 2025, its #361 holding.
  • Callan Capital first reported a position in Connect Biopharma Holdings in Q3 2024 and has held it in 3 quarters since.
  • Callan Capital's Connect Biopharma Holdings position peaked at $110K in Q4 2024.
  • 13 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q1 2025.

Based on Callan Capital's 13F filing for Q1 2025, filed 29 Apr 2025.